Clinical Trials Logo

Clinical Trial Summary

The overall purpose of this study is to evaluate the safety and efficacy of co-administration of tranexamic acid (TXA) with hyaluronic acid (HA) in reducing swelling, bruising and pain after facial injection. This will be done by comparing HA to HA+TXA in participants undergoing facial filler injections. Patients undergoing facial filler injections almost always have the same type of injection performed bilaterally in order to maintain symmetry. This provides a unique opportunity where participants can serve as their own controls. Participants will be injected with HA on half of their face and the other half of the face will be injected with HA+TXA. Swelling, bruising, pain, and overall satisfaction will be assessed using participant self-reported surveys, physician surveys, and review of medical records.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04373603
Study type Interventional
Source University of Wisconsin, Madison
Contact
Status Withdrawn
Phase Phase 4
Start date July 2022
Completion date July 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05109000 - Comparison of Subcutaneous Injection of Normal Saline and Bacteriostatic Saline Phase 4
Completed NCT05577832 - Testing Different Methods of Intramuscular Injection N/A
Completed NCT03645369 - Effectiveness of Mechano-Analgesia and Cold Application on Ecchymosis, Pain and Satisfaction at Subcutaneous Heparin Injection N/A
Completed NCT05771285 - Cold Application on the Subcutaneous Injection N/A